Nūhou ʻOihana

Hōʻike kahi noiʻi hou i ka pono kupaianaha o ka lāʻau lapaʻau CAR-T cell i ka mālama ʻana i ka B-cell Acute Lymphoblastic Leukemia (B-ALL). ʻO ka noiʻi, e pili ana i ka laulima ʻana me BIOOCUS a me ka Halemai ʻo Lu Daopei, e hōʻike ana i nā holomua koʻikoʻi, e hoʻokumu ana i ka lāʻau lapaʻau ma ke ʻano he koho lapaʻau koʻikoʻi.

Ke noiʻi nei nā kānaka noiʻi mai ka Halemai ʻo Lu Daopei a me nā hoa hana o ka honua i nā ʻano lapaʻau CAR-T cell hou loa, e hāʻawi ana i ka manaʻolana no nā poʻe maʻi me nā maʻi ʻino o nā cell B. Hōʻike kēia haʻawina i nā holomua i ka hoʻolālā a me ka hoʻohana ʻana, e hōʻike ana i nā hopena hoʻohiki a me ka hiki ke loaʻa nā hana hou e hiki mai ana.

Ua hōʻike nā haʻawina lapaʻau hou nei e hōʻike ana nā pūnaewele CD19 CAR-T i hoʻokumu ʻia ma 4-1BB i ka hopena antitumor maikaʻi loa i hoʻohālikelike ʻia me nā pūnaewele CAR-T i hoʻokumu ʻia ma CD28 i ka mālama ʻana i ka relapsed a i ʻole refractory B cell acute lymphoblastic leukemia (r/r B-ALL).

Ua hōʻike ʻia kahi noiʻi hou ma ka Halemai ʻo Lu Daopei i ka pono kiʻekiʻe a me ka palekana o ka lāʻau lapaʻau haʻahaʻa CD19 CAR-T cell i ka mālama ʻana i nā maʻi leukemia lymphoblastic B acute (B-ALL) paʻakikī a i ʻole ka relapsed. Ua hōʻike ka noiʻi, nona nā maʻi he 51, i kahi helu hoʻomaha piha kupaianaha me nā hopena ʻaoʻao liʻiliʻi.

Ua hoʻolaha ka Halemai ʻo Lu Daopei a me Hebei Senlang Biotechnology i nā ʻike hoʻohiki mai kā lākou noiʻi hou e pili ana i ka palekana a me ka pono o ka lāʻau lapaʻau CAR-T no ka maʻi leukemia B cell acute. Hōʻike kēia hana like i ka hiki o nā hoʻolālā cell CAR-T hou e hoʻomaikaʻi i nā hopena o ka mea maʻi.

Ua hōʻike ʻia kahi noiʻi hou i alakaʻi ʻia e Kauka Zhi-tao Ying mai ka Halemai Kanesa o ke Kulanui ʻo Peking i ka palekana a me ka pono o ka lāʻau lapaʻau IM19 CAR-T cell i ka mālama ʻana i nā maʻi hematologic B-cell i hoʻihoʻi ʻia a me nā mea paʻakikī. Paʻi ʻia ma ka Ka Nūpepa Kina no nā Lāʻau Lapaʻau Hou, ua hōʻike ka noiʻi ua loaʻa i ka 11 o 12 mau maʻi ke kala piha ʻana me ka ʻole o nā hopena maikaʻi ʻole, e hōʻike ana i ka hiki o IM19 ma ke ʻano he koho lapaʻau hoʻohiki no nā maʻi me nā koho ʻē aʻe i kaupalena ʻia.

Ua mālama pono ʻia ka Hoʻomaʻamaʻa Makahiki 2024 no ka Hoʻokele Koko Lapaʻau a me ka ʻenehana Hoʻoili Koko ma ke kūlanakauhale ʻo Sanhe ma ka Halemai ʻo Yanda Ludaopei. ʻO ka pahuhopu o kēia hanana e hoʻoikaika i ka hoʻokele koko lapaʻau a me ka palekana o ka hoʻoili koko ma o nā hālāwai hoʻomaʻamaʻa piha i hele ʻia e nā loea mālama ola kino he 100 a ʻoi mai nā ʻoihana lapaʻau like ʻole.

ʻO ka hōʻoia ʻana i kahi ʻike lapaʻau palekana a ʻoluʻolu hoʻi no nā maʻi leukemia e pili ana i ka mālama pono ʻana i kēlā me kēia lā, me ka hoʻomaʻemaʻe ʻana i ke kaiapuni, ka hoʻomaʻemaʻe pilikino, ka meaʻai, a me ka hoʻoikaika kino kūpono. Hāʻawi kēia alakaʻi i nā ʻōlelo aʻoaʻo koʻikoʻi no ka mālama pono ʻana i kēlā me kēia lā e kākoʻo i ka hoʻōla ʻana.

Ua hōʻike ʻia kahi noiʻi hou i ka pono a me ka palekana o ka lāʻau lapaʻau NS7CAR-T cell i ka mālama ʻana i ka relapsed a refractory T-cell acute lymphoblastic leukemia (R/R T-ALL) a me T-cell lymphoblastic lymphoma (R/R T-LBL). Hāʻawi kēia lāʻau lapaʻau i ka manaʻolana hou no nā poʻe maʻi me kēia mau ʻano maʻi ʻaʻai ikaika.

E mālama ʻia ana ka 12th Annual Lu Daopei Hematology Forum ma ʻAukake 23-24, 2024, ma ke Kikowaena ʻAha Kūkākūkā o Beijing International. E hui pū me mākou no nā kūkākūkā ʻike a me nā holomua hou loa i ka hematology.

Ua mālama ʻia kahi haʻawina lapaʻau pae I o CD7 CAR-T no R/R AML e ka hui a Daopei Lu ma ASH. Ua mālama ʻia ka 65th Annual Meeting o ka American Society of Hematology (ASH) ma waho pūnaewele (San Diego, USA) a ma ka pūnaewele ma Dekemaba 9-12, 2023. Ua hōʻike nui kā mākou poʻe haumāna i kēia hui...

ʻO ka American Society of Hematology (ASH) ka hālāwai hoʻonaʻauao kiʻekiʻe loa ma ke kahua o ka hematology ma ka honua holoʻokoʻa. ʻO ka ʻoiaʻiʻo ua koho ʻia ka Halemai ʻo Lu Daopei ma ke ʻano he finalist no ka ASH no nā makahiki i hala iho nei e hōʻike piha ana i kāna mau hoʻokō hoʻonaʻauao ma ka f...